Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis
Bing‐Dong Sui(Air Force Medical University), Yan Jin(Air Force Medical University)
Cited by 83
Related Papers
Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor κB pathway
|Stem Cell Research & Therapy|2014|149
Epigenetic inhibition of Wnt pathway suppresses osteogenic differentiation of BMSCs during osteoporosis
|Cell Death and Disease|2018|147
miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice
|Scientific Reports|2017|125
Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery
|Experimental & Molecular Medicine|2018|86